Entity coverage
AstraZeneca PLC
AZN · 6 events mapped
Market Ontology has mapped 6 distinct macro, policy, and market events to AZN. Each entry below traces the causal channel from the driver to the assumption it moved.
Recent event impacts
Full ledger →- 2026-07-15EventIncreased competition in the oncology market, particularly in NSCLC, from a strengthened GSK pipeline.
- 2026-06-29EventIncreased competition or market dynamics in the COPD market, potential for future M&A activity in the respiratory space.
- 2026-06-23EventPotential for future competition or collaboration in the lung cancer treatment market, specifically concerning PD-1/PD-L1 inhibitors.
- 2026-06-22EventPotential future competition or partnership opportunities in the PD-1/PD-L1 inhibitor market for lung cancer.
- 2026-06-22EventPotential future competition or partnership opportunities in the lung cancer treatment market, specifically concerning PD-1/PD-L1 inhibitors.
- 2026-06-22EventPotential future competition or partnership opportunities. AstraZeneca has PD-L1 inhibitors like Imfinzi (durvalumab) used in lung cancer.
Continuous coverage for AZN with alerts, structural playbooks, and options routing lives in the platform. Start a trial →